What Is AI Governance for Insurers?
AI governance for insurers is the management structure that determines how artificial intelligence systems are selected, developed, purchased, deployed, monitored, challenged, and retired. It assigns accountability for model risk, data quality, customer impact, regulatory compliance, security, and human oversight rather than leaving these duties with an IT team or individual model builder. Governance also records which decisions an AI system may make, which require human approval, and when use must stop. For insurers, this is especially important because automated systems may affect pricing, underwriting, claims handling, fraud detection, policy servicing, or customer eligibility. The direct answer is that insurers should treat AI as an enterprise-controlled business capability, not merely a software purchase. A documented model inventory, named owners, risk-tiered controls, independent testing, and auditable human decisions are more dependable than a general code of ethics.
Also worth reading: What is the insurance AI regulatory compliance framework and how do carriers manage model governance? · What Is Autonomous Underwriting Governance and How Should Insurers Control AI Decisions in 2026? · How do insurers implement effective AI regulatory compliance strategies in 2026?
Governance should cover generative AI, predictive analytics, machine learning, and ordinary rules-based automation, although their legal and operational risks differ. A rules engine that calculates a commission may require less evidence than a model that recommends denying a claim, but both still need ownership and change control. A useful starting threshold is impact-based: systems that touch money, sensitive personal data, or legally protected decisions deserve enhanced review, while low-risk productivity tools may follow a lighter process. Insurers should avoid claiming that a system is “explainable” merely because its developer understands the code. Explanation must be tested against the actual people and decisions affected, including whether a customer representative can understand the reason, correct an error, and know when a human will review the result.
Why AI Governance Has Become a Board-Level Issue
AI adoption is accelerating while regulatory attention is catching up. Research and industry reporting indicate that insurers expect AI spending to rise sharply, yet many organizations still have gaps between experimentation and formal control. S&P Global Ratings has argued that governance will separate stronger insurers from weaker ones because capital allocation, competition, and customer trust increasingly depend on responsible deployment. The concern is not simply that a model may be inaccurate. An insurer can face several losses at once: incorrect claim payments, regulatory penalties, remediation expenses, customer complaints, litigation, reputational damage, and disruption to a production workflow that handles thousands of files.
Regulation remains a combination of federal requirements, state insurance law, privacy and consumer-protection rules, and developing state AI legislation. The NAIC Model Bulletin on the Use of Artificial Intelligence Systems by Insurers gives regulators a common framework, but it is a model bulletin rather than a law that automatically applies in every jurisdiction. Insurers must therefore map each state in which they operate to its current adoption status and obligations. Colorado’s Artificial Intelligence Act illustrates why legal dates matter: its requirements concern “high-risk” AI systems, algorithmic discrimination, consumer notices, impact assessments, and reasonable care for known or reasonably foreseeable risks. As of September 29, 2026, counsel should confirm the final operative provisions and any amendments or court challenges rather than relying on an older compliance calendar.
The board’s role is to set risk appetite, require management reporting, and ensure adequate resources for control functions. Management should translate that direction into operating standards, while legal, compliance, risk, security, data, underwriting, claims, and internal audit should participate according to the system’s purpose. Governance that exists only as a presentation to the board is not working. It should produce evidence that exceptions are investigated, incidents are escalated, customer remedies are available, and models are revalidated after material change.
What an Effective Governance Operating Model Contains
A mature structure normally connects three documents: an enterprise policy, a use-case standard, and a model-specific control record. The enterprise policy defines acceptable use, prohibited uses, accountability, escalation, and review frequency. The use-case standard explains how risk classification works and identifies required functions. The model record contains the system owner, purpose, data sources, vendor dependencies, performance measures, affected populations, decision rights, human-review procedure, monitoring thresholds, and retirement plan. This is sometimes called a model inventory, but an inventory of names alone is insufficient; the record must show what each system does and how control effectiveness is tested.
The operating model should distinguish foundation models from the governance layers placed around them. A foundation model may supply general language, image recognition, coding, or reasoning capability, but it does not decide by itself how an insurer will use the output. Governance layers include data filtering, access controls, retrieval systems, prompting, output validation, approval rules, monitoring, audit records, and incident response. Separating these layers helps an insurer identify which provider or internal team is responsible for a failure. It also prevents excessive scrutiny of low-risk uses while concentrating review on decisions that directly affect customers.
A practical tiering system could use four categories. Tier 1 might cover spell-checking or internal drafting with no customer, financial, or operational effect. Tier 2 could include customer-service recommendations that do not determine eligibility or payment. Tier 3 could cover fraud alerts, claims triage, or underwriting support with meaningful operational impact. Tier 4 would include automated pricing, eligibility, claim denial, or other consequential decisions. The categories should reflect observed impact rather than vendor labels, and higher tiers should receive independent validation, periodic bias testing, stronger logging, documented human escalation, and more frequent recertification. Thresholds must be set by the insurer’s risk appetite, but no system affecting protected classes or material financial outcomes should automatically receive the same scrutiny as a low-risk summarization tool.
How Insurers Should Test Fairness, Accuracy, and Human Oversight
Testing should be tied to the purpose for which an insurer uses an AI system. Overall accuracy can conceal poor performance among protected groups, low-value claims, disputed cases, or unusual policy conditions. An evaluation set should reflect relevant customer populations and realistic operating conditions, with separate measures for false positives, false negatives, claim-value error, referral rates, and customer outcomes. Generative AI also requires tests for fabricated citations, invented policy terms, sensitive-data disclosure, prompt injection, harmful content, and refusal behavior. A model that writes a plausible answer can be wrong in a way that a conventional probability score makes easier to detect.
Fairness testing requires more than selecting one mathematical metric. Groups, proxies, severity, business relevance, and the legal context all matter, and different measures can produce conflicting results. Insurers should document which metrics they use, what trade-offs they accept, and who approves exceptions. Testing should also examine whether human reviewers can override an AI recommendation. Stanford University’s work on AI-driven insurance decisions has highlighted concern that nominal human oversight becomes cosmetic when staff do not have enough time, information, authority, or incentive to disagree with the system. Reviewers therefore need training, authority, access to the underlying evidence, and a record of changes made to the recommendation.
Control thresholds should indicate when operation pauses or requires investigation. Depending on the use case, these might include a material increase in adverse outcomes for a monitored group, a sustained breach of an accuracy or fairness limit, an unexpected change in referral volume, or evidence that the model is producing unsupported answers. Percentage tolerances should be calibrated to the harm and volume involved; a fixed 5% tolerance is not automatically sensible for either a million-dollar claim decision or a low-value service interaction. High-risk deployments may also need challenger testing, back-testing, stability checks, and comparison against a simple baseline, because complexity is justified only when it improves decisions or efficiency enough to justify its cost and control burden.
Practical Steps for an Insurer Starting in 2026
The first step is to identify existing and planned AI use across underwriting, actuarial functions, claims, fraud, distribution, compliance, marketing, investment, and administration. This discovery should include shadow systems, vendor tools embedded in existing platforms, spreadsheets that imitate models, and informal chatbot experiments. A small insurer can use a structured spreadsheet to begin, provided each entry identifies the owner, purpose, data, provider, users, affected customers, and decision impact. Larger insurers should place the inventory in a governed system with workflow, versioning, and reporting. A useful pilot target might be to inventory at least 95% of known AI applications within 90 days, followed by remediation of high-risk gaps, although the percentage is an internal management target rather than a regulatory standard.
The next step is to assign accountable owners and approve tiered standards. A model owner is usually the business executive responsible for the outcome, while a model-risk or control owner is independent of development. Developers, data teams, vendors, legal personnel, and regulators are participants but should not replace accountable business ownership. Insurers should then create intake, change, and decommission procedures. Material changes—such as new data, a revised prompt, a different foundation model, altered decision logic, or a new use population—should trigger reassessment. This is important because generative systems can behave differently after an apparently minor configuration change.
Prioritization should begin with consequential customer uses and sensitive data, not the most visible experiments. A pilot may proceed under limited conditions if it has a defined owner, approved data, an evaluation plan, restricted access, monitored users, customer remedies, and a clear stop date. A production system should not advance until control testing is complete and residual risks are accepted at the correct level of management. The insurer should also establish an incident channel and cross-functional response team. Incidents can be technical, such as data leakage, but they can also involve biased outcomes, inaccessible appeals, hallucinated coverage explanations, or a vendor change that bypasses approved controls.
Governance Options, Models, and Alternatives
Insurers have several ways to organize AI governance, and each has trade-offs. A centralized model-risk function offers consistency and independent challenge, but it can become a bottleneck if it lacks technical capacity. A decentralized structure places control close to product teams and can move faster, but inconsistent standards and conflicts of interest are more likely. A federated model is often a pragmatic compromise, combining a central policy and risk platform with business-specific control owners. No architecture is automatically best; the deciding factors are insurer size, system diversity, regulatory exposure, technical maturity, and available expertise.
| Feature | Centralized governance | Federated governance | Lightweight intake process |
|---|---|---|---|
| Control ownership | Central model-risk team leads | Central standards with business owners leading use cases | Business or IT coordinator manages intake |
| Strength | Consistent testing and independent challenge | Scales across lines while retaining local knowledge | Fast and inexpensive for low-risk pilots |
| Main weakness | Bottlenecks and distance from operations | More coordination and governance maturity required | May miss consequential or shadow systems |
| Best fit | Regulated insurers with many critical models | Diversified insurers adopting AI broadly | Small insurers beginning discovery |
| Scale trigger | High-risk inventory and substantial regulatory exposure | Multiple business units and shared platforms | Any system affecting customers, data, or money |
The alternative to extensive AI automation is sometimes better: simpler rules, conventional statistical models, or human-led work may be safer and cheaper. Insurers should compare expected value with total cost of ownership, including data preparation, integration, model validation, monitoring, audit work, security, training, vendor fees, and remediation. Vendors may quote only license or usage costs, which can obscure the expense of proving control effectiveness. A system that saves two hours of staff time but requires a permanent review team may be poor value, while a system that improves loss triage across 50,000 claims per month may justify stronger investment.
Common Mistakes That Make AI Governance Ineffective
One common mistake is treating governance as a procurement checkpoint. Signing a vendor assessment before deployment does not establish ongoing performance, and vendor questionnaires often describe the model rather than the insurer’s configuration and use. Another mistake is assuming a large third-party model is automatically safer because many customers use it. Foundation-model governance and application governance are distinct: a capable general model can still create discriminatory, private, or erroneous results when an insurer connects it to sensitive data or consequential workflows. “Human in the loop” is similarly weak if no competent person can change the result.
Other errors include testing only historical averages, using internal accuracy without testing operational performance, and failing to monitor changes in customer mix. A model can appear stable overall while producing worse outcomes for a smaller group, new claim type, changed fraud environment, or low-volume category. Documentation can also become performative if records are copied across systems and do not match production behavior. Insurers should test access rights, approved configurations, actual user permissions, and whether logged decisions can be reconstructed.
Premature bureaucracy is also a mistake. Review processes that require the same extensive approval for spelling tools and claim-denial models waste scarce expertise and discourage responsible experimentation. The answer is not an absence of control but proportionate control. Insurers should set service-level expectations for low-risk reviews, reserve expedited testing for genuinely time-sensitive pilots, and require fuller evidence for consequential systems. Metrics should track both outcomes and speed, including time to approve low-risk uses, time to close high-risk validation, number of overdue assessments, post-deployment issues, and customer correction rates. This makes governance an operating capability rather than a policy document.
When Insurers Should Act and What It May Cost
An insurer should act immediately if AI already influences pricing, claims, fraud decisions, eligibility, customer communications, or sensitive-data processing. Immediate action also becomes necessary when a vendor announces a material model update, a regulator examines the insurer’s use, complaints rise, monitoring detects a threshold breach, or a model’s purpose expands beyond its approved use. Organizations without consequential deployments should not wait for a crisis, but they should complete an inventory and assign responsibility before experimenting. A reasonable early program would first cover the highest-impact 20% of applications, then extend to shadow tools and lower-risk productivity uses.
Cost depends heavily on build-versus-buy decisions and the insurer’s starting point. External readiness reviews or limited governance-design engagements may begin in the tens of thousands of dollars, while enterprise-wide platforms, model validation, data controls, and ongoing monitoring can reach six or seven figures annually. Commercial foundation-model APIs may be inexpensive per user, but their price does not include data preparation, security, evaluation, review staff, and legal analysis. Internal staffing, fine-tuning, infrastructure, observability, audit preparation, and post-incident remediation can dominate the budget.
Insurers should compare these costs with the value at stake, which can include avoided losses, faster claims processing, reduced expenses, higher conversion, and better fraud detection. They should not promise a particular percentage return without a controlled baseline, because pilot results may reflect cherry-picked cases or temporary conditions. A practical business case should include a named baseline, expected value, control cost, downside scenarios, and a 6- or 12-month review date. The best insurer is not the one with the fastest AI rollout or the highest automated percentage; it is the one that can explain, measure, and correct how technology performs in real customer operations.